The new drug Taxotere should be approved to help prolong the lives of dying breast-cancer patients who have exhausted other options, despite its high incidence of dangerous side effects, a government panel recommended Tuesday.
If the Food and Drug Administration follows the advice, Taxotere would become the first competition for the widely used Taxol, which until now has been the last hope for many of these women.
The FDA isn’t bound by advisory committee decisions but usually follows them.
Local journalism is essential.
Give directly to The Spokesman-Review's Northwest Passages community forums series -- which helps to offset the costs of several reporter and editor positions at the newspaper -- by using the easy options below. Gifts processed in this system are not tax deductible, but are predominately used to help meet the local financial requirements needed to receive national matching-grant funds.
Subscribe to the Coronavirus newsletter
Get the day’s latest Coronavirus news delivered to your inbox by subscribing to our newsletter.